For the first time, our study delves into the relationship between autoantibodies and RA-CPFE, demonstrating that a high titer of RF and the presence of anti-SSA are linked to an increased risk of RA-CPFE. The gene discussed is TRIM21; the disease is rheumatoid arthritis.